Cargando…

Potential Benefits to Dairy Cow Welfare of Using a Ceftiofur–Ketoprofen Combination Drug for the Treatment of Inflammatory Disease Associated with Pyrexia: A Field Clinical Trial on Acute Puerperal Metritis

SIMPLE SUMMARY: Some diseases of dairy cows require the use of an antimicrobial and an anti-inflammatory drug in association to be fully cured and relieve pain. However, pharmacological treatments in cattle are subject to strict regulations and restrictions, and cow handling is not always easy and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Lora, Isabella, Massignani, Mattia, Stefani, Annalisa, Gottardo, Flaviana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228903/
https://www.ncbi.nlm.nih.gov/pubmed/34071561
http://dx.doi.org/10.3390/ani11061597
_version_ 1783712851533234176
author Lora, Isabella
Massignani, Mattia
Stefani, Annalisa
Gottardo, Flaviana
author_facet Lora, Isabella
Massignani, Mattia
Stefani, Annalisa
Gottardo, Flaviana
author_sort Lora, Isabella
collection PubMed
description SIMPLE SUMMARY: Some diseases of dairy cows require the use of an antimicrobial and an anti-inflammatory drug in association to be fully cured and relieve pain. However, pharmacological treatments in cattle are subject to strict regulations and restrictions, and cow handling is not always easy and safe. For these reasons, only the antimicrobial is often administered, thus not fully applying the appropriate therapeutic protocol. This study investigated whether the use of a drug combining ceftiofur and ketoprofen in a single injection instead of ceftiofur alone can improve the healing and welfare of dairy cows affected by a pyretic inflammatory disease, such as acute puerperal metritis. The results show that the variation in the physiological parameters was similar between the two treatment groups, and daily activity and milk yield did not differ from healthy cows. However, affected cows that were treated with the combined drug seemed to be more likely to become pregnant within 120 days in milk than those that received the antimicrobial alone, having an estimated number of days open more similar to that of the healthy cows. ABSTRACT: This study aimed at investigating the benefits of using a drug combining ceftiofur and ketoprofen in a single injection on dairy cow welfare in the case of inflammatory disease with pyrexia, such as acute puerperal metritis (APM). Cows of an Italian dairy farm were examined between 5 and 14 days of calving: those with APM were randomly treated either with combined ceftiofur–ketoprofen (CD) or ceftiofur alone (C), starting from Day 0, and an equal number of healthy cows served as a control (CTR). Clinical examination and blood sampling were performed until Day 7 in each group according to specific schedules. Daily cow activity was recorded until Day 14 and daily milk production until Day 30. Additional data on fertility were collected until 120 days in milk (DIM). Data of 20 cows per group were analyzed. Body temperature and haptoglobin concentration dropped between Day 0 and 4 in both CD and C, approaching the level of CTR. The cure rate at Day 7 (body temperature < 39.0 °C) was 65 (CD) and 55% (C), without statistical difference. Neither cow activity nor milk production differed among the three groups. Reproductive performances in both CD and C were similar to CTR, but CD cows were 2.8 times more likely to be pregnant within 120 DIM than C, becoming pregnant about 14 days sooner. Both treatments (CD and C) have been effective in bringing the cows back to health conditions (CTR), and further studies would be needed to confirm the positive effect observed for CD on days open of the affected cows.
format Online
Article
Text
id pubmed-8228903
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82289032021-06-26 Potential Benefits to Dairy Cow Welfare of Using a Ceftiofur–Ketoprofen Combination Drug for the Treatment of Inflammatory Disease Associated with Pyrexia: A Field Clinical Trial on Acute Puerperal Metritis Lora, Isabella Massignani, Mattia Stefani, Annalisa Gottardo, Flaviana Animals (Basel) Article SIMPLE SUMMARY: Some diseases of dairy cows require the use of an antimicrobial and an anti-inflammatory drug in association to be fully cured and relieve pain. However, pharmacological treatments in cattle are subject to strict regulations and restrictions, and cow handling is not always easy and safe. For these reasons, only the antimicrobial is often administered, thus not fully applying the appropriate therapeutic protocol. This study investigated whether the use of a drug combining ceftiofur and ketoprofen in a single injection instead of ceftiofur alone can improve the healing and welfare of dairy cows affected by a pyretic inflammatory disease, such as acute puerperal metritis. The results show that the variation in the physiological parameters was similar between the two treatment groups, and daily activity and milk yield did not differ from healthy cows. However, affected cows that were treated with the combined drug seemed to be more likely to become pregnant within 120 days in milk than those that received the antimicrobial alone, having an estimated number of days open more similar to that of the healthy cows. ABSTRACT: This study aimed at investigating the benefits of using a drug combining ceftiofur and ketoprofen in a single injection on dairy cow welfare in the case of inflammatory disease with pyrexia, such as acute puerperal metritis (APM). Cows of an Italian dairy farm were examined between 5 and 14 days of calving: those with APM were randomly treated either with combined ceftiofur–ketoprofen (CD) or ceftiofur alone (C), starting from Day 0, and an equal number of healthy cows served as a control (CTR). Clinical examination and blood sampling were performed until Day 7 in each group according to specific schedules. Daily cow activity was recorded until Day 14 and daily milk production until Day 30. Additional data on fertility were collected until 120 days in milk (DIM). Data of 20 cows per group were analyzed. Body temperature and haptoglobin concentration dropped between Day 0 and 4 in both CD and C, approaching the level of CTR. The cure rate at Day 7 (body temperature < 39.0 °C) was 65 (CD) and 55% (C), without statistical difference. Neither cow activity nor milk production differed among the three groups. Reproductive performances in both CD and C were similar to CTR, but CD cows were 2.8 times more likely to be pregnant within 120 DIM than C, becoming pregnant about 14 days sooner. Both treatments (CD and C) have been effective in bringing the cows back to health conditions (CTR), and further studies would be needed to confirm the positive effect observed for CD on days open of the affected cows. MDPI 2021-05-28 /pmc/articles/PMC8228903/ /pubmed/34071561 http://dx.doi.org/10.3390/ani11061597 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lora, Isabella
Massignani, Mattia
Stefani, Annalisa
Gottardo, Flaviana
Potential Benefits to Dairy Cow Welfare of Using a Ceftiofur–Ketoprofen Combination Drug for the Treatment of Inflammatory Disease Associated with Pyrexia: A Field Clinical Trial on Acute Puerperal Metritis
title Potential Benefits to Dairy Cow Welfare of Using a Ceftiofur–Ketoprofen Combination Drug for the Treatment of Inflammatory Disease Associated with Pyrexia: A Field Clinical Trial on Acute Puerperal Metritis
title_full Potential Benefits to Dairy Cow Welfare of Using a Ceftiofur–Ketoprofen Combination Drug for the Treatment of Inflammatory Disease Associated with Pyrexia: A Field Clinical Trial on Acute Puerperal Metritis
title_fullStr Potential Benefits to Dairy Cow Welfare of Using a Ceftiofur–Ketoprofen Combination Drug for the Treatment of Inflammatory Disease Associated with Pyrexia: A Field Clinical Trial on Acute Puerperal Metritis
title_full_unstemmed Potential Benefits to Dairy Cow Welfare of Using a Ceftiofur–Ketoprofen Combination Drug for the Treatment of Inflammatory Disease Associated with Pyrexia: A Field Clinical Trial on Acute Puerperal Metritis
title_short Potential Benefits to Dairy Cow Welfare of Using a Ceftiofur–Ketoprofen Combination Drug for the Treatment of Inflammatory Disease Associated with Pyrexia: A Field Clinical Trial on Acute Puerperal Metritis
title_sort potential benefits to dairy cow welfare of using a ceftiofur–ketoprofen combination drug for the treatment of inflammatory disease associated with pyrexia: a field clinical trial on acute puerperal metritis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228903/
https://www.ncbi.nlm.nih.gov/pubmed/34071561
http://dx.doi.org/10.3390/ani11061597
work_keys_str_mv AT loraisabella potentialbenefitstodairycowwelfareofusingaceftiofurketoprofencombinationdrugforthetreatmentofinflammatorydiseaseassociatedwithpyrexiaafieldclinicaltrialonacutepuerperalmetritis
AT massignanimattia potentialbenefitstodairycowwelfareofusingaceftiofurketoprofencombinationdrugforthetreatmentofinflammatorydiseaseassociatedwithpyrexiaafieldclinicaltrialonacutepuerperalmetritis
AT stefaniannalisa potentialbenefitstodairycowwelfareofusingaceftiofurketoprofencombinationdrugforthetreatmentofinflammatorydiseaseassociatedwithpyrexiaafieldclinicaltrialonacutepuerperalmetritis
AT gottardoflaviana potentialbenefitstodairycowwelfareofusingaceftiofurketoprofencombinationdrugforthetreatmentofinflammatorydiseaseassociatedwithpyrexiaafieldclinicaltrialonacutepuerperalmetritis